Singapore’s efforts in building a thriving research, innovation and enterprise (RIE) sector have borne fruit in many areas. Investments in biomedical sciences and medical technology have seen the sector grow to support more than 25,000 jobs, making up almost 4 per cent of Singapore’s gross domestic product.
Singapore’s start-up ecosystem is continuing to grow, with venture capital funding raised here increasing more than 20 times, from about $500 million in 2011 to about $11 billion in 2022.
These accomplishments were detailed in an addendum released by the National Research Foundation (NRF) under the Prime Minister’s Office on Wednesday, following President Halimah Yacob’s address at the opening of the new session of Parliament earlier in the week.
The NRF, which was set up in 2006, sets the national direction for research and development (R&D) by enacting policies, plans and strategies.
In addition to their economic importance, efforts in the RIE sector have been critical in addressing Singapore’s challenges in areas such as public health and resource resilience, said Deputy Prime Minister Heng Swee Keat, who is Chairman of the NRF.
He raised the example of Singapore’s capabilities in biomedical science and infectious diseases that enabled the country to respond to Covid-19 quickly. Singapore was one of the first countries to culture the virus, developing several diagnostic test kits that were deployed for use both locally and overseas.